<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://repositorio.ufc.br/handle/riufc/303">
    <title>DSpace Coleção:</title>
    <link>http://repositorio.ufc.br/handle/riufc/303</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://repositorio.ufc.br/handle/riufc/86472" />
        <rdf:li rdf:resource="http://repositorio.ufc.br/handle/riufc/86240" />
        <rdf:li rdf:resource="http://repositorio.ufc.br/handle/riufc/86227" />
        <rdf:li rdf:resource="http://repositorio.ufc.br/handle/riufc/85329" />
      </rdf:Seq>
    </items>
    <dc:date>2026-05-31T16:46:25Z</dc:date>
  </channel>
  <item rdf:about="http://repositorio.ufc.br/handle/riufc/86472">
    <title>Nanopartículas à base de quitosana e polietilenoglicol para encapsulamento do 5-fluorouracil</title>
    <link>http://repositorio.ufc.br/handle/riufc/86472</link>
    <description>Título: Nanopartículas à base de quitosana e polietilenoglicol para encapsulamento do 5-fluorouracil
Autor(es): Paiva Junior, José Ribamar
Abstract: Cancer is becoming a serious threat to public health. Among non-communicable diseases, it is the most prevalent worldwide. Conventional cancer treatments include chemotherapy, radiotherapy, and, in more severe cases, surgery. Among the chemotherapeutic agents used, 5-fluorouracil is widely used in various types of cancer (colon, stomach, and others). However, it presents some problems, including a very short half-life, low bioavailability, and multiple side effects, including liver and kidney damage. Nanoencapsulation is an alternative to overcome these challenges. Nanoparticles (NPs) have excellent characteristics for controlled drug release&#xD;
applications. They can be prepared using a variety of techniques, with ionotropic gelation being one of the most widely used. This combines oppositely charged polymers, with one of them acting as a cross-linking agent. Chitosan (CH) is a naturally occurring, positively charged polysaccharide extensively used in drug delivery systems. Tripolyphosphate (TPP) can be used&#xD;
as a crosslinking agent to produce nanoparticles. Polyethylene glycol is a synthetic polymer that provides longer intravenous circulation time, better diffusion of NPs in tissue, and prevents interactions with other blood components, increasing the bioavailability of the encapsulated material. In this study, eight nanoparticle systems were developed: four without 5-FU and four&#xD;
with 5-FU. The systems showed encapsulation efficiencies ranging from 9% to 28% and carrying capacities of 8.4% to 12.2%. The FTIR spectra of the systems displayed all the characteristic bands of the starting materials. The diameter of the nanoparticles without 5-FU ranged from 146 nm to 303 nm, and with 5-FU, it ranged from 187 nm to 396 nm. The release presented burst release, releasing approximately 55% within 48 hours of the assay, with release kinetics consistent with the diffusion mechanism model. Scanning electron microscopy&#xD;
revealed that the nanoparticles had a spherical morphology. The PEG-containing systems did not exhibit significant interaction with the protein, suggesting a possible longer circulation time for intravenous administration. Cell viability, however, showed that encapsulated 5-FU was more effective against the HCT-116 cell line, with the systems CH/TPP/PEG14505-FU and&#xD;
CH/TPP/PEG3350/5-FU being the most effective in the evaluations performed. The system CH/TPP/PEG1450/5-FU also demonstrated the emergence of encapsulated 5-FU against the MDA-MB-231 cell line, demonstrating great potential for anticancer applications.
Tipo: Tese</description>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repositorio.ufc.br/handle/riufc/86240">
    <title>Hidrogéis via base de Schiff a partir de ciclodextrina e polissacarídeos modificados: veículos para curcumina</title>
    <link>http://repositorio.ufc.br/handle/riufc/86240</link>
    <description>Título: Hidrogéis via base de Schiff a partir de ciclodextrina e polissacarídeos modificados: veículos para curcumina
Autor(es): Oliveira, Matheus Xavier de
Abstract: Curcumin (CUR) is a polyphenol with anti-inflammatory, antioxidant, and antimicrobial properties; however, its application is limited due to its low solubility and stability under physiological conditions. To overcome these limitations, CUR was initially encapsulated in 2-hydroxypropyl-β-cyclodextrin (HP-β-CD), forming 1:1 inclusion complexes with a high complexation constant (4.65 × 10³ at 25 °C). The use of ultrasound for 10 min (HP-CD/Cur10) increased solubility (from 0.42 to 156 µg mL−1) and stability (half-life from 281 to 2139 min), while also providing antibacterial activity against S. aureus MRSA, greater bioaccessibility, and biocompatibility. In the second stage, HP-CD/Cur10 was incorporated into a hydrogel composed of succinylated chitosan and oxidized cashew gum (GEL-50B), resulting in the GEL-Cur4 formulation, which showed a high curcumin content (440 µg mL−1), mechanical and thermal stability, as well as injectability, self-healing, and adhesiveness. CUR release demonstrated pH responsiveness, increasing intestinal bioaccessibility from 0.20 to 13.5% and enhancing antibacterial activity against K. pneumoniae (85% vs. 59% in the control). In an in vivo wound model, GEL-Cur4 accelerated healing (71% vs. 41% in the control) and positively modulated markers of inflammation and oxidative stress. Therefore, the novel system developed represents a promising multifunctional matrix for wound healing and oral curcumin delivery.
Tipo: Tese</description>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repositorio.ufc.br/handle/riufc/86227">
    <title>Nanopartículas pH-responsivas de goma do cajueiro para terapia combinada contra o câncer</title>
    <link>http://repositorio.ufc.br/handle/riufc/86227</link>
    <description>Título: Nanopartículas pH-responsivas de goma do cajueiro para terapia combinada contra o câncer
Autor(es): Gomes, Raelle Ferreira
Abstract: Cancer is a serious public health problem worldwide, and chemotherapy is considered the first-line approach in treating this disease. However, therapeutic effectiveness is limited by adverse events and the low bioavailability associated with chemotherapeutic agents. Combining two or more therapeutic agents represents an important strategy to enhance anticancer effects through synergistic actions and simultaneous accumulation in the tumor microenvironment. Polysaccharide-based pH-responsive prodrug nanocarriers show promise as co-delivery systems in cancer therapy. To demonstrate this, in this study, carboxymethyl cashew gum (CMCG) was successfully conjugated with curcumin (CUR) to form an acid-sensitive prodrug (CMCG-CUR). Paclitaxel (PTX) and resiquimod (R848) were then encapsulated in CMCG-CUR nanoparticles (CMCG-CUR/PTX and CMCG-CUR/R848) through non-covalent interactions. These nanoparticles were designed to promote the co-delivery of drugs to the tumor microenvironment. The structures of the prodrugs were confirmed by infrared spectroscopy and hydrogen nuclear magnetic resonance. Self-assembly into nanoparticles was observed using fluorescence spectroscopy, dynamic light scattering, and atomic force microscopy, indicating good dispersion and diameters below 200 nm. The drug loading values for CUR in the CMCG-CUR, CMCG-CUR/PTX, and CMCG-CUR/R848 nanoparticles were 7.0%, 3.0%, and 2.0%, respectively. The nanoparticles protected CUR from degradation and exhibited a controlled pH-responsive release profile. Furthermore, the CMCG-CUR and CMCG-CUR/PTX nanoparticles showed in vitro activity against CT-26 cells (murine colorectal carcinoma) and reduced cytotoxicity in non-tumor cells (RAW 264.7, murine macrophages), with a greater effect observed in the co-administration of CUR/PTX than the free drug. On the other hand, the CMCG-CUR/R848 nanoparticle showed no cytotoxicity in CT-26 cells but induced a proliferative effect in RAW 264.7 immune cells. The cell uptake study confirmed that the nanoparticles with CUR/PTX were absorbed by CT-26 cells, while those containing CUR/R848 were absorbed by RAW 264.7 cells. pH-responsive polysaccharide-based nanoparticles have shown promise for the selective and controlled co-delivery of drugs to the tumor microenvironment, with potential application in combination cancer therapies.
Tipo: Tese</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repositorio.ufc.br/handle/riufc/85329">
    <title>Molibdato de zinco (ZnMoO4) e seus compósitos com TiO2 para aplicações em componentes de alta frequência em comunicações</title>
    <link>http://repositorio.ufc.br/handle/riufc/85329</link>
    <description>Título: Molibdato de zinco (ZnMoO4) e seus compósitos com TiO2 para aplicações em componentes de alta frequência em comunicações
Autor(es): Martins, Vitor Carvalho
Abstract: Currently, the telecommunications area presents new demands and, consequently, challenges in the development of antennas, among them, the need for higher data transmission and greater information transport capacity. Thus, research into new dielectric ceramics ensures the evolution of telecommunications systems. In this work, the dielectric properties of composites based on zinc molybdate and titanium dioxide (ZnMoO4-TiO2) and possible application as dielectric resonator antenna (DRA) was investigated. The ZnMoO4 phase (ZMO) and its ceramic composites were obtained at low sintering temperatures in the proportions of 0.22, 0.27, and 0.36 in mole % of TiO2 and identified by X-ray diffraction. The insertion of TiO2 in the ZMO altered the structural characteristics and consequently the dielectric properties. In the radio frequency (RF) range, the samples exhibit low values of relative permittivity (εr) and dielectric loss tangent (tan δ), where their values decrease as frequency increases. The normalization curves showed the presence of short-range movement of charge carriers, with a thermally activated relaxation process (formation of  relaxation peaks). The conductivity (σ) inthe samples obeys Jonscher's power law. Similar activation energies (Ea) (σdc e pela Z”) indicate that the samples have the same insulating character. The ZMT36 sample is the only one that does not show RF thermal stability in the range of 100 kHz to 1 MHz. The Nyquist diagrams were well adjusted using an equivalent electrical circuit, making it possible to measure the contributions of the grain region and grain boundary of the material in the electrical response of the samples. The measurements in microwaves (MW) show that these materials have low εr and tgδ, and the TiO2 addition in mol of 0.22 and 0.27 have a resonant frequency temperature coeficiente tend to zero (– 7.39 and + 2.18 ppm °C-1, respectively). In antenna measurements, ZnMoO4 showed a gain of 4.63 dBi, radiation efficiency of 82.37%, and bandwidth of 1.147 GHz. All composites had their properties improved and exhibited good performance in terms of gain above 5 dBi, bandwidth (498 – 622 MHz), efficiency above 97%, and operating frequency range of 5.288 – 5.428 GHz. Thus, ZMO forms LTCC composites with TiO2 showing its applicability in RF and MW devices.
Tipo: Tese</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

